<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35115852</article-id>
      <article-id pub-id-type="pmc">8800372</article-id>
      <article-id pub-id-type="publisher-id">344299</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S344299</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nightmares in People with COVID-19: Did Coronavirus Infect Our Dreams?</article-title>
        <alt-title alt-title-type="running-authors">Scarpelli et al</alt-title>
        <alt-title alt-title-type="running-title">Scarpelli et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9260-7111</contrib-id>
          <name>
            <surname>Scarpelli</surname>
            <given-names>Serena</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nadorff</surname>
            <given-names>Michael R</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7051-745X</contrib-id>
          <name>
            <surname>Bjorvatn</surname>
            <given-names>Bjørn</given-names>
          </name>
          <xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Frances</given-names>
          </name>
          <xref rid="aff0005" ref-type="aff">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dauvilliers</surname>
            <given-names>Yves</given-names>
          </name>
          <xref rid="aff0006" ref-type="aff">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Espie</surname>
            <given-names>Colin A</given-names>
          </name>
          <xref rid="aff0007" ref-type="aff">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Inoue</surname>
            <given-names>Yuichi</given-names>
          </name>
          <xref rid="aff0008" ref-type="aff">
<sup>8</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsui</surname>
            <given-names>Kentaro</given-names>
          </name>
          <xref rid="aff0009" ref-type="aff">
<sup>9</sup>
</xref>
          <xref rid="aff0010" ref-type="aff">
<sup>10</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1222-6678</contrib-id>
          <name>
            <surname>Merikanto</surname>
            <given-names>Ilona</given-names>
          </name>
          <xref rid="aff0011" ref-type="aff">
<sup>11</sup>
</xref>
          <xref rid="aff0012" ref-type="aff">
<sup>12</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morin</surname>
            <given-names>Charles M</given-names>
          </name>
          <xref rid="aff0013" ref-type="aff">
<sup>13</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4304-0112</contrib-id>
          <name>
            <surname>Penzel</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref rid="aff0014" ref-type="aff">
<sup>14</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8219-2912</contrib-id>
          <name>
            <surname>Sieminski</surname>
            <given-names>Mariusz</given-names>
          </name>
          <xref rid="aff0015" ref-type="aff">
<sup>15</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0364-8457</contrib-id>
          <name>
            <surname>Fang</surname>
            <given-names>Han</given-names>
          </name>
          <xref rid="aff0016" ref-type="aff">
<sup>16</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1474-4329</contrib-id>
          <name>
            <surname>Macêdo</surname>
            <given-names>Tainá</given-names>
          </name>
          <xref rid="aff0017" ref-type="aff">
<sup>17</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mota-Rolim</surname>
            <given-names>Sérgio A</given-names>
          </name>
          <xref rid="aff0018" ref-type="aff">
<sup>18</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1168-480X</contrib-id>
          <name>
            <surname>Leger</surname>
            <given-names>Damien</given-names>
          </name>
          <xref rid="aff0019" ref-type="aff">
<sup>19</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1051-0472</contrib-id>
          <name>
            <surname>Plazzi</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <xref rid="aff0020" ref-type="aff">
<sup>20</sup>
</xref>
          <xref rid="aff0021" ref-type="aff">
<sup>21</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Ngan Yin</given-names>
          </name>
          <xref rid="aff0022" ref-type="aff">
<sup>22</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Partinen</surname>
            <given-names>Markku</given-names>
          </name>
          <xref rid="aff0023" ref-type="aff">
<sup>23</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2297-2778</contrib-id>
          <name>
            <surname>Bolstad</surname>
            <given-names>Courtney J</given-names>
          </name>
          <xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5385-4091</contrib-id>
          <name>
            <surname>Holzinger</surname>
            <given-names>Brigitte</given-names>
          </name>
          <xref rid="aff0024" ref-type="aff">
<sup>24</sup>
</xref>
          <xref rid="aff0025" ref-type="aff">
<sup>25</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3613-6631</contrib-id>
          <name>
            <surname>De Gennaro</surname>
            <given-names>Luigi</given-names>
          </name>
          <xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff0026" ref-type="aff">
<sup>26</sup>
</xref>
          <xref rid="an0001" ref-type="corresp"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Psychology, Sapienza University of Rome</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff>
        <aff id="aff0002"><label>2</label><institution>Mississippi State University</institution>, <addr-line>Mississippi State</addr-line>, <addr-line>MS</addr-line>, <country>USA</country></aff>
        <aff id="aff0003"><label>3</label><institution>Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine</institution>, <addr-line>Houston</addr-line>, <addr-line>TX</addr-line>, <country>USA</country></aff>
        <aff id="aff0004"><label>4</label><institution>Department of Public Health and Primary Care, University of Bergen and Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital</institution>, <addr-line>Bergen</addr-line>, <country>Norway</country></aff>
        <aff id="aff0005"><label>5</label><institution>Department of Anesthesiology and Pain Medicine, University Health Network, University of Toronto</institution>, <addr-line>Toronto</addr-line>, <country>Canada</country></aff>
        <aff id="aff0006"><label>6</label><institution>Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, INM, Univ Montpellier, INSERM</institution>, <addr-line>Montpellier</addr-line>, <country>France</country></aff>
        <aff id="aff0007"><label>7</label><institution>Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford</institution>, <addr-line>Oxford</addr-line>, <country>UK</country></aff>
        <aff id="aff0008"><label>8</label><institution>Tokyo Medical University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff0009"><label>9</label><institution>Department of Laboratory Medicine, National Center Hospital, National Center of Neurology and Psychiatry</institution>, <addr-line>Kodaira</addr-line>, <country>Japan</country></aff>
        <aff id="aff0010"><label>10</label><institution>Department of Psychiatry, Tokyo Women’s Medical University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff0011"><label>11</label><institution>SleepWell Research Program, Faculty of Medicine, University of Helsinki</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
        <aff id="aff0012"><label>12</label><institution>Department of Public Health Solutions, Finnish Institute for Health and Welfare</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
        <aff id="aff0013"><label>13</label><institution>École de Psychologie, Centre d’étude des troubles du sommeil, Centre de recherche CERVO/Brain Research Center, Université Laval</institution>, <addr-line>Québec</addr-line>, <country>Canada</country></aff>
        <aff id="aff0014"><label>14</label><institution>Sleep Medicine Center, Charité Universitätsmedizin Berlin</institution>, <addr-line>Berlin</addr-line>, <country>Germany</country></aff>
        <aff id="aff0015"><label>15</label><institution>Department of Emergency Medicine, Medical University of Gdansk</institution>, <addr-line>Gdansk</addr-line>, <country>Poland</country></aff>
        <aff id="aff0016"><label>16</label><institution>Department of Pulmonary and Critical Care Medicine, Peking University People’s Hospital</institution>, <addr-line>Beijing</addr-line>, <country>People’s Republic of China</country></aff>
        <aff id="aff0017"><label>17</label><institution>Department of Psychology, Federal University of Rio Grande do Norte</institution>, <addr-line>Natal</addr-line>, <country>Brazil</country></aff>
        <aff id="aff0018"><label>18</label><institution>Brain Institute, Physiology and Behavior Department, and Onofre Lopes University Hospital - Federal University of Rio Grande do Norte</institution>, <addr-line>Natal</addr-line>, <country>Brazil</country></aff>
        <aff id="aff0019"><label>19</label><institution>Université de Paris, APHP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance</institution>, <addr-line>Paris</addr-line>, <country>France</country></aff>
        <aff id="aff0020"><label>20</label><institution>IRCCS, Istituto delle Scienze Neurologiche di Bologna</institution>, <addr-line>Bologna</addr-line>, <country>Italy</country></aff>
        <aff id="aff0021"><label>21</label><institution>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia</institution>, <addr-line>Modena</addr-line>, <country>Italy</country></aff>
        <aff id="aff0022"><label>22</label><institution>Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong</institution>, <addr-line>Shatin</addr-line>, <country>Hong Kong, Special Administrative Regions, People’s Republic of China</country></aff>
        <aff id="aff0023"><label>23</label><institution>Helsinki Sleep Clinic, Terveystalo Healthcare, and Department of Neurosciences, Clinicum, University of Helsinki</institution>, <addr-line>Helsinki</addr-line>, <country>Finland</country></aff>
        <aff id="aff0024"><label>24</label><institution>Institute for Consciousness and Dream Research</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country></aff>
        <aff id="aff0025"><label>25</label><institution>Medical University Vienna, Postgraduate Master Program Medical Sleep Coaching, ZK-Schlafcoaching</institution>, <addr-line>Vienna</addr-line>, <country>Austria</country></aff>
        <aff id="aff0026"><label>26</label><institution>IRCCS Fondazione Santa Lucia</institution>, <addr-line>Rome</addr-line>, <country>Italy</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Luigi De Gennaro, <phone>Tel +39-06-49917647</phone>, <fax>Fax +39-06-49917711</fax>, Email luigi.degennaro@uniroma1.it</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>1</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>14</volume>
      <fpage>93</fpage>
      <lpage>108</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>10</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>1</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2022 Scarpelli et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Scarpelli et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec sec-type="intro" id="s2001">
          <title>Introduction</title>
          <p>A growing number of studies have demonstrated that the coronavirus disease-19 (COVID-19) pandemic has severely affected sleep and dream activity in healthy people. To date, no investigation has examined dream activity specifically in COVID-19 patients.</p>
        </sec>
        <sec id="s2002">
          <title>Methods</title>
          <p>As part of the International COVID-19 Sleep Study (ICOSS), we compared 544 COVID-19 participants with 544 matched-controls. A within-subjects comparison between pre-pandemic and pandemic periods computed separately for controls and COVID-19 participants were performed on dream recall and nightmare frequency (DRF; NF). Also, non-parametric comparisons between controls and COVID-19 participants were carried out. Further, we compared psychological measures between the groups collected during pandemic. Ordinal logistic regression to detect the best predictors of NF was performed.</p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p>We found that people reported greater dream activity during the pandemic. Comparisons between controls and COVID-19 participants revealed a) no difference between groups concerning DRF in the pre-pandemic period and during the pandemic; b) no difference between groups concerning nightmare frequency in the pre-pandemic period; and c) COVID-19 participants reported significantly higher NF than controls during pandemic (p = 0.003). Additionally, we showed that a) anxiety, depression, post-traumatic stress-disorder (PTSD) symptom scores were higher in COVID-19 participants than controls; and b) quality of life and health as well as wellbeing (WHO-5) scores were significantly higher in controls than COVID-19 participants. Finally, ordinal logistic regression indicates that DRF (p &lt; 0.001), PTSD (p &lt; 0.001), anxiety (p = 0.018), insomnia (p = 0.039), COVID-19 severity (p = 0.014), sleep duration (p = 0.003) and age (p = 0.001) predicted NF.</p>
        </sec>
        <sec id="s2004">
          <title>Discussion</title>
          <p>Our work shows strong associations between increased nightmares in those reporting having had COVID-19. This suggests that the more that people were affected by COVID-19, the greater the impact upon dream activity and quality of life.</p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>dreaming</kwd>
        <kwd>pandemic</kwd>
        <kwd>sleep</kwd>
        <kwd>PTSD</kwd>
        <kwd>anxiety</kwd>
        <kwd>COVID-19 severity</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
<institution-wrap><institution>did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors</institution></institution-wrap>
</funding-source>
        </award-group>
        <funding-statement>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="8"/>
        <ref-count count="78"/>
        <page-count count="16"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p>In March 2020, the World Health Organization (WHO) proclaimed the novel Coronavirus disease outbreak (COVID-19) to be a global pandemic. COVID-19 is characterized by a severe acute respiratory syndrome and much clinical and research attention has been paid to finding an effective treatment or prevention strategy to defeat the virus.</p>
      <p>In the last year, an impressive number of studies has focused on the psychological consequences of the pandemic both on the worldwide population<xref rid="cit0001" ref-type="bibr">1</xref> and infected people.<xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0003" ref-type="bibr">3</xref></p>
      <p>In particular, a growing literature has highlighted that the COVID-19 pandemic strongly affected Sleep.<xref rid="cit0004" ref-type="bibr">4–9</xref> Among the general population, cross-sectional investigations found dysregulation in sleep-wake schedules<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0010" ref-type="bibr">10</xref> and insomnia symptoms.<xref rid="cit0011" ref-type="bibr">11–13</xref> Additionally, a recent review emphasized that COVID-19 patients have higher prevalence rates of sleep disturbances.<xref rid="cit0012" ref-type="bibr">12</xref> On the one hand, the fear related with the virus may be one of the main reasons for poor sleep quality. On the other hand, it should be noted that the core symptoms of the infection such as fever, coughing, breathing difficulties and physical pain, are highly correlated with sleep, problems.<xref rid="cit0014" ref-type="bibr">14–16</xref> Moreover, hospitalization (pharmacological treatments for the infection could contribute to sleep disruption).<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0017" ref-type="bibr">17</xref></p>
      <p>In parallel with sleep problems, several studies show that the pandemic is associated with alterations of dreams and nightmares among healthy people.<xref rid="cit0018" ref-type="bibr">18–25</xref></p>
      <p>From a qualitative point of view, healthy individuals have reported higher negative emotional intensity in dream content during the COVID-19 outbreak.<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0026" ref-type="bibr">26</xref> Moreover, pandemic-related contents were identified both during the first wave of pandemic<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0027" ref-type="bibr">27–29</xref> and in the post-lockdown period.<xref rid="cit0025" ref-type="bibr">25</xref> In a relatively large United States sample (N = 3031), dream activity and mental health were shown to be associated during the pandemic, with the finding that the more participants were affected by the pandemic, the more it affected their dreams.<xref rid="cit0027" ref-type="bibr">27</xref> Similarly, individuals having COVID-19-related traumatic experiences, such as death or disease of relatives/friends, report increased distress in their dream content<xref rid="cit0020" ref-type="bibr">20</xref> and nightmares.<xref rid="cit0024" ref-type="bibr">24</xref> Further, people reporting more changes in their life situation (eg, sleep habits or working life) have more emotional dreams.<xref rid="cit0024" ref-type="bibr">24</xref> Furthermore, some trait-like features have an impact on oneiric activity. Indeed, women have shown higher DRF than men,<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0026" ref-type="bibr">26</xref> and older adults have reported lower (dream recall frequency) DRF<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> and (nightmare frequency) NF<xref rid="cit0024" ref-type="bibr">24</xref> than younger individuals.</p>
      <p>Importantly, sleep patterns and oneiric activity appear to be strictly related since poor sleep quality predicts high DRF and NF during the lockdown.<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> Also, a longitudinal study revealed a greater lucid dream frequency during lockdown than post-lockdown.<xref rid="cit0025" ref-type="bibr">25</xref></p>
      <p>An international investigation highlighted that sleep disturbances and parasomnia-like events such as sleep talking and REM sleep behavior disorder symptoms are associated with high DRF.<xref rid="cit0014" ref-type="bibr">14</xref> Further, psychological variables influence the quantitative features of oneiric activity since Post-Traumatic Stress Disorder (PTSD) symptoms are related to DRF,<xref rid="cit0022" ref-type="bibr">22</xref> and both anxiety<xref rid="cit0024" ref-type="bibr">24</xref> and depression<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> are associated with high NF.</p>
      <p>Although the literature evidenced the high proportion of sleep disturbances among COVID-19 patients,<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0012" ref-type="bibr">12</xref> to the best of our knowledge, we have no information on the oneiric activity of people with COVID-19 and no study has compared the oneiric activity of those who have had COVID-19 and those who have not. This research is crucial for several reasons. First, we are beginning to understand some of the long-term consequences of the virus including physical,<xref rid="cit0030" ref-type="bibr">30</xref>,<xref rid="cit0031" ref-type="bibr">31</xref> cognitive,<xref rid="cit0032" ref-type="bibr">32</xref>,<xref rid="cit0033" ref-type="bibr">33</xref> and mental health<xref rid="cit0034" ref-type="bibr">34</xref> changes. Given these changes, it is very likely that there are notable differences in sleep and dreaming that come subsequently to infection. Importantly, nightmares have been linked with many forms of psychopathology such as anxiety and depression,<xref rid="cit0035" ref-type="bibr">35</xref> borderline personality disorder,<xref rid="cit0036" ref-type="bibr">36</xref> and suicidal behavior and mortality,<xref rid="cit0037" ref-type="bibr">37</xref> even when accounting for the effects of post-traumatic stress disorder and related Disorders.<xref rid="cit0038" ref-type="bibr">38–40</xref> Thus, the development of nightmares is clinically relevant.</p>
      <p>To fill this notable gap in the literature, we aimed to investigate the relationship between COVID-19 and oneiric activity. Since participants who experienced greater life changes due to COVID-19 pandemic had more disturbing dreams or contents related to the disease outbreak,<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0027" ref-type="bibr">27</xref> we predicted that individuals who have had COVID-19 would report greater changes in their dreams than those without COVID-19, especially concerning nightmares. Second, we hypothesized that COVID-19-related factors, such as the illness severity and quarantine duration, would be associated with participants’ nightmares.</p>
    </sec>
    <sec id="s0002">
      <title>Materials and Methods</title>
      <sec id="s0002-s2001">
        <title>Study Design and Participants</title>
        <p>The current research protocol is part of a wider project by the International COVID-19 Sleep Study (ICOSS).<xref rid="cit0041" ref-type="bibr">41</xref> Fourteen countries/regions including Austria, Brazil, Canada, Hong Kong, Province Jilin (China), Finland, France, Italy, Japan, Norway, Sweden, Poland, the UK, and the USA were involved in the cross-sectional study. Each participant filled out a web-survey between May and July 2020. Different web-platforms, (eg, REDcap, Qualtrics) were used to distribute the online-survey, which was translated into the national language of each country. To recruit a large number of participants, the web-survey was promoted via university communication systems, newspapers, social-media platforms, newsletters to hospitals, and through sleep societies’ websites.</p>
        <p>Investigators from each country obtained ethical approval from the local ethics committee, if needed according to local legislations. The study was approved by the Institutional Ethics Committee of the Department of Psychology of “Sapienza” University of Rome and was conducted in accordance with the Declaration of Helsinki (protocol number: 0000836, May 23rd, 2020). Subjects had to be at least 18 years of age and agreed voluntarily and anonymously to take part in the survey. All participants provided electronic informed consent before accessing the web-survey. General data protection regulations were applied to ensure privacy and confidentiality.</p>
        <p>Data from 544 participants declaring they have had COVID-19 (they answered “yes” to the question: “Have you had COVID-19?”) and 544 matched-controls were extracted from respondents (25,500 participants) and included in the current investigation. The control group was matched according to the following criteria: age, gender, country, ethnicity, type of residential area, marital status, education, work, quarantine duration. Both asymptomatic and symptomatic subjects with different degrees of infection severity were included in the COVID-19 group.</p>
        <p>Other data concerning the whole sample and analyzed with different aims have been reported elsewhere.<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0042" ref-type="bibr">42</xref></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Instruments</title>
        <p>The web-survey included a section collecting sociodemographic information (age, gender, ethnicity, country, residential area, marital status, education, work) and COVID-19-related information (infection, severity, confinement duration). Also, information about hypnotic’s usage and financial burden were collected.</p>
        <p>The questionnaires used to assess psychological dimensions are described below:
<list list-type="order"><list-item><p><italic toggle="yes">Generalized Anxiety Disorder-2</italic> (GAD-2).<xref rid="cit0043" ref-type="bibr">43</xref> A 2-item short form of the GAD-7 evaluated anxiety on scales of 0 to 3. A score of three is the recommended cut-off for detecting significant anxiety symptoms.</p></list-item><list-item><p><italic toggle="yes">Patient Health Questionnaire-2</italic> (PHQ-2).<xref rid="cit0043" ref-type="bibr">43</xref> A 2-item abbreviated version of the PHQ-9 assessed depression disturbances on scales of 0 to 3. A score of 3 is the cut-off for identifying clinically relevant symptoms of depression.</p></list-item><list-item><p><italic toggle="yes">Stress</italic>.<xref rid="cit0044" ref-type="bibr">44</xref> A single item (1–5 rating) evaluated the current stress from “not at all” to “very much”.</p></list-item><list-item><p><italic toggle="yes">Post-traumatic stress disorder</italic>.<xref rid="cit0045" ref-type="bibr">45</xref> Two items were used to assess the key symptoms of PTSD. Respondents rated their symptoms on scales of 1 to 5.</p></list-item><list-item><p><italic toggle="yes">Well-Being Index</italic> (WHO-5).<xref rid="cit0046" ref-type="bibr">46</xref> A short questionnaire of 5 statements to assess the overall psychological wellbeing. In relation to the past two weeks, respondents rated each item on 0–5 scales. The raw score is multiplied by four, resulting in a total score from 0 to 100. Higher scores indicate a better quality of life.</p></list-item><list-item><p><italic toggle="yes">Quality of life and health</italic>.<xref rid="cit0047" ref-type="bibr">47</xref> Two items using 0–100 linear visual analog scales measured the quality of life and quality of health.</p></list-item></list></p>
        <p>The questionnaires used to assess sleep and dream variables are described below:
<list list-type="order"><list-item><p><italic toggle="yes">Basic Nordic sleep questionnaire</italic>.<xref rid="cit0048" ref-type="bibr">48</xref> This instrument assessed sleep onset and sleep maintenance problems, early morning awakenings, use of hypnotics, sleepiness and fatigue. Respondents rated each item on a scale from 1 to 5, based on how many nights per week sleep problems occurred (1= “Never or less frequently than once per month”, 2= “Less frequently than once per week”, 3= “1–2 nights per week”, 4= “3–5 nights per week”, 5= “Nightly or almost nightly”). Similarly, two items were added to assess dream recall frequency and nightmares. Sleep quality was evaluated on a scale from 1 (well) to 5 (badly). All statements were rated “during the pandemic” and “before the pandemic”. Specifically, the questionnaire required to answer each question referring to the COVID-19 emergency (ie, pandemic period) and the period immediately preceding the time of confinement/restrictions/social isolation (ie, pre-pandemic period).</p></list-item><list-item><p><italic toggle="yes">Insomnia Severity Index</italic> (ISI).<xref rid="cit0049" ref-type="bibr">49</xref> A 7-item questionnaire was used to evaluate the severity of nighttime and daytime symptoms of insomnia during the past week before answering the survey, rated on a scale of 0 to 4. A total score of 0–7 indicates no insomnia, 8 to 14 subthreshold clinical insomnia, 15 to 21 insomnia of moderate severity, and 22 and above indicates severe insomnia.</p></list-item></list></p>
        <p>Specifically, the following variables were extracted: the wellbeing (WHO-5) score, the quality of life, and quality of health measures; the GAD and PHQ measures dichotomized accordingly to their cut-off (3);<xref rid="cit0043" ref-type="bibr">43</xref> the stress score dichotomized considering cut-off = 3; the ISI score dichotomized accordingly to its cut-off for clinical insomnia (15);<xref rid="cit0049" ref-type="bibr">49</xref> the DRF; the NF; sleep quality categorized as good (well, rather well, neither well nor badly) and poor (rather badly, badly); the sleep duration categorized as short (&lt;6 hours), normal (6–8 hours), and long (≥9 hours);<xref rid="cit0050" ref-type="bibr">50</xref>,<xref rid="cit0051" ref-type="bibr">51</xref> the PTSD measures dichotomized as low risk (&lt;3) and high risk (≥3). Also, among socio-demographic and COVID-19 related variables were considered: age; gender; quarantine duration categorized as ≤ 1 month and &gt; 1 month; self-reported COVID-19-severity categorized as low (no symptoms or mild) and high (moderate or severe symptoms and/or life threatening).</p>
        <p>The selection of dependent measures was based on (a) the findings of other studies published during pandemic<xref rid="cit0018" ref-type="bibr">18–28</xref> and (b) the need to avoid any overlapping (ie, duplication of results) with results of other publications of the ICOSS group.<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0042" ref-type="bibr">42</xref> The complete protocol is available on Partinen et al.<xref rid="cit0041" ref-type="bibr">41</xref></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Statistical Analysis</title>
        <p>The statistical procedures were carried out using the Statistical Package for Social Sciences (<sc>SPSS</sc>) version 25.0 and MATLAB R2019. First, descriptive analyses were carried out to outline the sociodemographic characteristics of the COVID-19 participants and the control group considering the following features: age, gender, ethnicity, residential area, marital status, living alone, education, and work status.</p>
        <p>To assess the differences concerning oneiric activity, non-parametric within comparisons (Wilcoxon test) between pre-pandemic and pandemic periods were computed separately for controls and COVID-19 participants. Further, non-parametric comparisons (Mann–Whitney test) between controls and COVID-19 participants were performed on DRF and NF.</p>
        <p>Also, for a descriptive purpose, we compared psychological measures (wellbeing, quality of life, quality of health, symptoms of anxiety, depression, stress, and PTSD) between the two groups. Data on insomnia were not included in these analyses, since this comparison in people with or without COVID has been reported elsewhere.<xref rid="cit0013" ref-type="bibr">13</xref></p>
        <p>According to the hypothesis of the study, an ordinal logistic regression analysis in the COVID-19 group was performed to explore the role of psychological variables, sleep measures, quarantine duration, and COVID-19-severity on nightmare frequency (dependent variable). Specifically, the following predictors have been included: PTSD-repeated disturbing thoughts/memories (low risk, high risk), anxiety (yes, no), depression (yes, no), stress (yes, no), DRF (from 1 to 5), sleep quality (good, poor), sleep duration (long, normal, short), insomnia (yes, no), quality of life, quality of health, wellbeing, quarantine duration (≤ 1 month, &gt; 1 month), COVID-19 severity (low, high). Considering the well-known effect of age and gender on dreaming,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> we adjusted the model for these two variables. We entered the variables simultaneously into a single model. Multicollinearity between the independent variables was assessed before running the logistic regression by calculating Variance Inflation Factors (VIF). The VIF statistics for all variables included in the regression model were under three, indicating only moderate correlation.</p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Characteristics of Samples</title>
        <p>The characteristics of participants are shown in <xref rid="t0001" ref-type="table">Table 1</xref>. Data from 1088 subjects revealed that the majority of participants were female (about 60% in both groups). The most represented age range was 34–44 years (27–28%). Concerning ethnicity, participants were mostly Caucasian (controls: 63.1%; COVID-19 participants: 60.9%) and nearly 25% of samples in both groups came from the USA. More than 80% of the subjects in both groups resided in urban areas. Most of the individuals were married/cohabiting both among controls (59.2%) and COVID-19 individuals (60.4%). Respondents mainly were graduates with a bachelor’s degree both among controls (41.9%) and COVID-19 participants (39.7%). More than half of the subjects had a regular day work in both groups. Also, nearly 40% of participants had a forced quarantine lasting more than a month in both groups. Approximately 70% of controls and 60% of COVID-19 participants reported using hypnotics “never or less frequently than once per month”. Finally, just a small percentage of individuals (controls: 4.4%; COVID-19 participants: 6.8%) reported a high degree of financial burden during the pandemic.<table-wrap position="float" id="t0001"><label>Table 1</label><caption><p>Characteristics of Participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Controls N (%)</th><th align="center" rowspan="1" colspan="1">COVID-19 Participants N (%)</th></tr></thead><tbody><tr><td colspan="3" rowspan="1"><bold>Gender (C: n=544; CP: n=544)</bold></td></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">219 (40.3)</td><td rowspan="1" colspan="1">215 (39.5)</td></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">325 (59.7)</td><td rowspan="1" colspan="1">329 (60.5)</td></tr><tr><td colspan="3" rowspan="1"><bold>Age, years (C: n=544; CP: n=544)</bold></td></tr><tr><td rowspan="1" colspan="1">&lt;25</td><td rowspan="1" colspan="1">81 (14.9)</td><td rowspan="1" colspan="1">81 (14.9)</td></tr><tr><td rowspan="1" colspan="1">25–34</td><td rowspan="1" colspan="1">102 (18.7)</td><td rowspan="1" colspan="1">100 (18.4)</td></tr><tr><td rowspan="1" colspan="1">35–44</td><td rowspan="1" colspan="1">149 (27.4)</td><td rowspan="1" colspan="1">154 (28.3)</td></tr><tr><td rowspan="1" colspan="1">45–54</td><td rowspan="1" colspan="1">99 (18.2)</td><td rowspan="1" colspan="1">99 (18.2)</td></tr><tr><td rowspan="1" colspan="1">55–64</td><td rowspan="1" colspan="1">64 (11.8)</td><td rowspan="1" colspan="1">64 (11.8)</td></tr><tr><td rowspan="1" colspan="1">65+</td><td rowspan="1" colspan="1">49 (9)</td><td rowspan="1" colspan="1">46 (8.5)</td></tr><tr><td colspan="3" rowspan="1"><bold>Ethnicity (C: n=544; CP: n=539)</bold></td></tr><tr><td rowspan="1" colspan="1">Caucasian</td><td rowspan="1" colspan="1">343 (63.1)</td><td rowspan="1" colspan="1">328 (60.9)</td></tr><tr><td rowspan="1" colspan="1">Asian</td><td rowspan="1" colspan="1">71 (13.1)</td><td rowspan="1" colspan="1">74 (13.7)</td></tr><tr><td rowspan="1" colspan="1">African</td><td rowspan="1" colspan="1">56 (10.3)</td><td rowspan="1" colspan="1">60 (11.1)</td></tr><tr><td rowspan="1" colspan="1">Hispanic</td><td rowspan="1" colspan="1">41 (7.5)</td><td rowspan="1" colspan="1">46 (8.5)</td></tr><tr><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">33 (6.1)</td><td rowspan="1" colspan="1">31 (5.8)</td></tr><tr><td colspan="3" rowspan="1"><bold>Country (C: n=544; CP: n=544)</bold></td></tr><tr><td rowspan="1" colspan="1">Austria</td><td rowspan="1" colspan="1">9 (1.7)</td><td rowspan="1" colspan="1">9 (1.7)</td></tr><tr><td rowspan="1" colspan="1">Brazil</td><td rowspan="1" colspan="1">76 (14.0)</td><td rowspan="1" colspan="1">87 (16.0)</td></tr><tr><td rowspan="1" colspan="1">Canada</td><td rowspan="1" colspan="1">42 (7.7)</td><td rowspan="1" colspan="1">35 (6.4)</td></tr><tr><td rowspan="1" colspan="1">China, Hong Kong</td><td rowspan="1" colspan="1">2 (0.4)</td><td rowspan="1" colspan="1">2 (0.4)</td></tr><tr><td rowspan="1" colspan="1">China, Jilin</td><td rowspan="1" colspan="1">11 (2.0)</td><td rowspan="1" colspan="1">10 (1.8)</td></tr><tr><td rowspan="1" colspan="1">Finland</td><td rowspan="1" colspan="1">21 (3.9)</td><td rowspan="1" colspan="1">23 (4.2)</td></tr><tr><td rowspan="1" colspan="1">France</td><td rowspan="1" colspan="1">37 (6.8)</td><td rowspan="1" colspan="1">33 (6.1)</td></tr><tr><td rowspan="1" colspan="1">Italy</td><td rowspan="1" colspan="1">26 (4.8)</td><td rowspan="1" colspan="1">25 (4.6)</td></tr><tr><td rowspan="1" colspan="1">Japan</td><td rowspan="1" colspan="1">61 (11.2)</td><td rowspan="1" colspan="1">63 (11.6)</td></tr><tr><td rowspan="1" colspan="1">Norway</td><td rowspan="1" colspan="1">17 (3.1)</td><td rowspan="1" colspan="1">21 (3.9)</td></tr><tr><td rowspan="1" colspan="1">Poland</td><td rowspan="1" colspan="1">3 (0.6)</td><td rowspan="1" colspan="1">4 (0.7)</td></tr><tr><td rowspan="1" colspan="1">Sweden</td><td rowspan="1" colspan="1">59 (10.8)</td><td rowspan="1" colspan="1">50 (9.2)</td></tr><tr><td rowspan="1" colspan="1">UK</td><td rowspan="1" colspan="1">43 (7.9)</td><td rowspan="1" colspan="1">46 (8.5)</td></tr><tr><td rowspan="1" colspan="1">USA</td><td rowspan="1" colspan="1">137 (25.2)</td><td rowspan="1" colspan="1">136 (25.0)</td></tr><tr><td colspan="3" rowspan="1"><bold>Residential area (C: n=543; CP: n=541)</bold></td></tr><tr><td rowspan="1" colspan="1">Rural</td><td rowspan="1" colspan="1">98 (18.1)</td><td rowspan="1" colspan="1">91 (16.8)</td></tr><tr><td rowspan="1" colspan="1">Urban</td><td rowspan="1" colspan="1">445 (81.9)</td><td rowspan="1" colspan="1">450 (83.2)</td></tr><tr><td colspan="3" rowspan="1"><bold>Marital status (C: n=544; CP: n=543)</bold></td></tr><tr><td rowspan="1" colspan="1">Single</td><td rowspan="1" colspan="1">184 (33.8)</td><td rowspan="1" colspan="1">171 (31.5)</td></tr><tr><td rowspan="1" colspan="1">Married/cohabiting</td><td rowspan="1" colspan="1">322 (59.2)</td><td rowspan="1" colspan="1">328 (60.4)</td></tr><tr><td rowspan="1" colspan="1">Divorced/separated</td><td rowspan="1" colspan="1">29 (5.3)</td><td rowspan="1" colspan="1">35 (6.4)</td></tr><tr><td rowspan="1" colspan="1">Widowed</td><td rowspan="1" colspan="1">9 (1.7)</td><td rowspan="1" colspan="1">9 (1.7)</td></tr><tr><td colspan="3" rowspan="1"><bold>Education (C: n=544; CP: n=543)</bold></td></tr><tr><td rowspan="1" colspan="1">Primary</td><td rowspan="1" colspan="1">7 (1.3)</td><td rowspan="1" colspan="1">9 (1.7)</td></tr><tr><td rowspan="1" colspan="1">Secondary</td><td rowspan="1" colspan="1">58 (10.7)</td><td rowspan="1" colspan="1">67 (12.3)</td></tr><tr><td rowspan="1" colspan="1">Vocational</td><td rowspan="1" colspan="1">45 (8.3)</td><td rowspan="1" colspan="1">47 (8.7)</td></tr><tr><td rowspan="1" colspan="1">Bachelor</td><td rowspan="1" colspan="1">228 (41.9)</td><td rowspan="1" colspan="1">216 (39.7)</td></tr><tr><td rowspan="1" colspan="1">Master</td><td rowspan="1" colspan="1">164 (30.1)</td><td rowspan="1" colspan="1">160 (29.5)</td></tr><tr><td rowspan="1" colspan="1">Doctor</td><td rowspan="1" colspan="1">42 (7.7)</td><td rowspan="1" colspan="1">44 (8.1)</td></tr><tr><td colspan="3" rowspan="1"><bold>Work (C: n=539; CP: n=539)</bold></td></tr><tr><td rowspan="1" colspan="1">Regular day work</td><td rowspan="1" colspan="1">305 (56.6)</td><td rowspan="1" colspan="1">283 (52.5)</td></tr><tr><td rowspan="1" colspan="1">Irregular day work</td><td rowspan="1" colspan="1">48 (8.9)</td><td rowspan="1" colspan="1">52 (9.7)</td></tr><tr><td rowspan="1" colspan="1">Student</td><td rowspan="1" colspan="1">59 (10.9)</td><td rowspan="1" colspan="1">47 (8.7)</td></tr><tr><td rowspan="1" colspan="1">Shift/night work</td><td rowspan="1" colspan="1">30 (5.6)</td><td rowspan="1" colspan="1">58 (10.8)</td></tr><tr><td rowspan="1" colspan="1">At home, no salary</td><td rowspan="1" colspan="1">19 (3.5)</td><td rowspan="1" colspan="1">20 (3.7)</td></tr><tr><td rowspan="1" colspan="1">Temporary laid off</td><td rowspan="1" colspan="1">15 (2.8)</td><td rowspan="1" colspan="1">18 (3.3)</td></tr><tr><td rowspan="1" colspan="1">Unemployed</td><td rowspan="1" colspan="1">28 (5.2)</td><td rowspan="1" colspan="1">26 (4.8)</td></tr><tr><td rowspan="1" colspan="1">Retired</td><td rowspan="1" colspan="1">30 (5.6)</td><td rowspan="1" colspan="1">26 (4.8)</td></tr><tr><td rowspan="1" colspan="1">Lost job due to pandemic</td><td rowspan="1" colspan="1">5 (0.9)</td><td rowspan="1" colspan="1">9 (1.7)</td></tr><tr><td colspan="3" rowspan="1"><bold>Quarantine duration (C: n=527; CP: n=537)</bold></td></tr><tr><td rowspan="1" colspan="1">≤ 1 month</td><td rowspan="1" colspan="1">302 (57.3)</td><td rowspan="1" colspan="1">320 (59.6)</td></tr><tr><td rowspan="1" colspan="1">&gt; 1 month</td><td rowspan="1" colspan="1">225 (42.7)</td><td rowspan="1" colspan="1">217 (40.4)</td></tr><tr><td colspan="3" rowspan="1"><bold>Hypnotics usage (C: n=544; CP: n=544)</bold></td></tr><tr><td rowspan="1" colspan="1">Never or less frequently than once per month</td><td rowspan="1" colspan="1">389 (71.5)</td><td rowspan="1" colspan="1">342 (62.9)</td></tr><tr><td rowspan="1" colspan="1">Less frequently than once per week</td><td rowspan="1" colspan="1">52 (9.6)</td><td rowspan="1" colspan="1">41 (7.5)</td></tr><tr><td rowspan="1" colspan="1">1–2 nights per week</td><td rowspan="1" colspan="1">33 (6.1)</td><td rowspan="1" colspan="1">75 (13.8)</td></tr><tr><td rowspan="1" colspan="1">3–5 nights per week</td><td rowspan="1" colspan="1">33 (6.1)</td><td rowspan="1" colspan="1">43 (7.9)</td></tr><tr><td rowspan="1" colspan="1">Every night or almost every night</td><td rowspan="1" colspan="1">37 (6.8)</td><td rowspan="1" colspan="1">43 (7.9)</td></tr><tr><td colspan="3" rowspan="1"><bold>Financial burden (C: n=544; CP: n=544)</bold></td></tr><tr><td rowspan="1" colspan="1">Not at all</td><td rowspan="1" colspan="1">221 (40.6)</td><td rowspan="1" colspan="1">172 (31.6)</td></tr><tr><td rowspan="1" colspan="1">A little</td><td rowspan="1" colspan="1">159 (29.2)</td><td rowspan="1" colspan="1">132 (24.3)</td></tr><tr><td rowspan="1" colspan="1">Somewhat</td><td rowspan="1" colspan="1">98 (18)</td><td rowspan="1" colspan="1">115 (21.1)</td></tr><tr><td rowspan="1" colspan="1">Much</td><td rowspan="1" colspan="1">42 (7.7)</td><td rowspan="1" colspan="1">88 (16.2)</td></tr><tr><td rowspan="1" colspan="1">Very much</td><td rowspan="1" colspan="1">24 (4.4)</td><td rowspan="1" colspan="1">37 (6.8)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Abbreviations</bold>: C, controls; CP, COVID-19 participants.</p></fn></table-wrap-foot></table-wrap>
</p>
        <p>Descriptive data on dream variables (DRF and NF) across different countries were reported in <underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=344299.docx" ext-link-type="uri">Figures S1</ext-link></underline> and <underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=344299.docx" ext-link-type="uri">S2</ext-link></underline>.</p>
      </sec>
      <sec id="s0003-s2002">
        <title>Differences in the Oneiric Activity: Controls versus COVID-19 Participants</title>
        <p>First, we explored how the two groups were different concerning the variables related to oneiric activity. The within-comparisons (Wilcoxon test) between pre-pandemic and pandemic periods (<underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=344299.docx" ext-link-type="uri">Table S1</ext-link></underline>), computed separately for controls and COVID-19 participants, revealed significant differences (<italic toggle="yes">p</italic>&lt;0.001) in DRF and nightmare frequency (<xref rid="f0001" ref-type="fig">Figure 1</xref>), highlighting that during pandemic people reported greater oneiric activity.<fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p>Oneiric frequency changes between pre-pandemic and pandemic period. (<bold>A</bold>) shows the results of non-parametric (within) comparisons on Dream Recall Frequency (DRF) between pre-pandemic (black bars) vs pandemic period (grey bars), performed separately for the controls and COVID-19 group. (<bold>B</bold>) depicts the results of non-parametric comparisons on Nightmare Frequency (NF) between pre-pandemic (black bars) vs pandemic period (grey bars) performed separately for the controls and COVID-19 group. Error bars represent the standard errors. Significant results are asterisked. ***<italic toggle="yes">p</italic>&lt;0.001.</p></caption><graphic xlink:href="NSS-14-93-g0001" content-type="print-only" position="float"/></fig></p>
        <p>Crucially, non-parametric comparisons (Mann–Whitney test) between controls and COVID-19 participants (<underline><ext-link xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=344299.docx" ext-link-type="uri">Table S2</ext-link></underline>), revealed a) no difference between groups concerning DRF in the pre-pandemic period and during pandemic; b) no difference between groups concerning NF in the pre-pandemic period; and c) COVID-19 participants reported significantly higher NF than controls during pandemic (<italic toggle="yes">p</italic>=0.003; <xref rid="f0002" ref-type="fig">Figure 2</xref>).<fig position="float" id="f0002" fig-type="figure"><label>Figure 2</label><caption><p>Oneiric frequency differences between controls and COVID-19 participants. (<bold>A</bold>) shows the results of non-parametric (between) comparisons on Dream Recall Frequency (DRF) between controls (black bars) vs COVID-19 participants (grey bars), performed separately for the pre-pandemic and pandemic period. (<bold>B</bold>) depicts the results of non-parametric comparisons on Nightmare Frequency (NF) between controls (black bars) vs COVID-19 participants (grey bars) performed separately for the pre-pandemic and pandemic period. Error bars represent the standard errors. Significant results are asterisked. **<italic toggle="yes">p</italic>&lt;0.01.</p></caption><graphic xlink:href="NSS-14-93-g0002" content-type="print-only" position="float"/></fig></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Comparisons for Clinical Variables During Pandemic</title>
        <p>Second, we then assessed whether the two groups differ in terms of some psychological and clinical variables during pandemic. The comparisons between the control group and the COVID-19 group showed that: a) symptoms of anxiety (<italic toggle="yes">p</italic>=0.001), depression (<italic toggle="yes">p</italic>=0.001), PTSD (repeated disturbing thoughts/memories, <italic toggle="yes">p</italic>=0.003 and feeling very upset about past, <italic toggle="yes">p</italic>=0.002) scores were higher in COVID-19 participants than controls; and b) quality of life (<italic toggle="yes">p</italic>=0.005) and quality of health (<italic toggle="yes">p</italic>&lt;0.001), as well as Wellbeing (WHO-5) scores (<italic toggle="yes">p</italic>=0.002) were significantly higher in controls than COVID-19 participants (<xref rid="t0002" ref-type="table">Table 2</xref>).<table-wrap position="float" id="t0002"><label>Table 2</label><caption><p>Mean Rank of Clinical Measures and Results of Statistical Comparisons (Mann–Whitney <italic toggle="yes">U</italic>-Test) Between Controls and COVID-19 Participants (Controls N=544; COVID-19 Participants= 544) During Pandemic</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="1"/><th rowspan="1" colspan="1">Mean Rank</th><th rowspan="1" colspan="1">Z</th><th rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td rowspan="2" colspan="1"><bold>Anxiety</bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">514.07</td><td rowspan="2" colspan="1">−3.24</td><td rowspan="2" colspan="1"><bold>0.001</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">574.93</td></tr><tr><td rowspan="2" colspan="1"><bold>Depression</bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">512.18</td><td rowspan="2" colspan="1">−3.44</td><td rowspan="2" colspan="1"><bold>0.001</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">576.82</td></tr><tr><td rowspan="2" colspan="1"><bold>Stress<sup>a</sup></bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">529.82</td><td rowspan="2" colspan="1">−1.33</td><td rowspan="2" colspan="1">0.184</td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">554.25</td></tr><tr><td rowspan="2" colspan="1"><bold>PTSD: repeated disturbing thoughts/memories</bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">517.32</td><td rowspan="2" colspan="1">−2.95</td><td rowspan="2" colspan="1"><bold>0.003</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">571.68</td></tr><tr><td rowspan="2" colspan="1"><bold>PTSD: feeling very upset about past</bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">515.85</td><td rowspan="2" colspan="1">−3.06</td><td rowspan="2" colspan="1"><bold>0.002</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">572.20</td></tr><tr><td rowspan="2" colspan="1"><bold>Quality of Life<sup>b</sup></bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">570.63</td><td rowspan="2" colspan="1">−2.80</td><td rowspan="2" colspan="1"><bold>0.005</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">517.32</td></tr><tr><td rowspan="2" colspan="1"><bold>Quality of Health<sup>c</sup></bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">593.02</td><td rowspan="2" colspan="1">−5.26</td><td rowspan="2" colspan="1"><bold>&lt;0.001</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">493.08</td></tr><tr><td rowspan="2" colspan="1"><bold>Wellbeing (WHO-5)</bold></td><td rowspan="1" colspan="1">Controls</td><td rowspan="1" colspan="1">573.94</td><td rowspan="2" colspan="1">−3.09</td><td rowspan="2" colspan="1"><bold>0.002</bold></td></tr><tr><td rowspan="1" colspan="1">COVID-19 participants</td><td rowspan="1" colspan="1">515.06</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><bold>Notes</bold>: <sup>a</sup>Controls = 543, COVID-19 participants = 540. <sup>b</sup>Controls = 544, COVID-19 participants = 543. <sup>c</sup>Controls = 542, COVID-19 participants = 543. Significant values are indicated in bold.</p></fn><fn id="tfn0003"><p><bold>Abbreviation</bold>: PTSD, post-traumatic stress disorder.</p></fn></table-wrap-foot></table-wrap>
</p>
      </sec>
      <sec id="s0003-s2004">
        <title>Predictors of Nightmare Frequency in COVID-19 Participants</title>
        <p>Third, we have determined the best predictor variables for the most robust variable associated with dream activity that discriminated the two groups. To this aim, ordinal logistic regression model was computed on 499 COVID-19 participants (after excluding subjects with missing values). The outcome provided a significant model: likelihood ratio: chi-squared = 286.50, <italic toggle="yes">p</italic> &lt; 0.001; Negelkerke’s R<sup>2</sup> = 0.46.</p>
        <p>The analysis revealed that higher NF was associated with a) DRF (daily or almost daily: Odds Ratio [OR]= 19.26, 95% Confidence Interval [CI]: 9.38, 39.57; 3–5 days per week: OR=11.54, 95% CI: 6.01, 22.14; 1–2 days per week: OR=9.67, 95% CI: 5.11, 18.31; less frequently than once per week: OR=2.82, 95% CI: 1.47, 5.41); b) PTSD symptoms (OR= 2.58, 95% CI: 1.67, 3.96); c) anxiety symptoms (OR= 1.76, 95% CI: 1.10, 2.81); d) insomnia symptoms (OR= 1.63, 95% CI: 1.02, 2.60); e) COVID-19 severity (OR= 1.60, 95% CI: 1.10, 2.34); f) sleep duration (long: OR= 0.43, 95% CI: 0.25, 0.75; normal: OR= 0.55, 95% CI: 0.35, 0.87) and g) age (55–64 years: OR= 0.29, 95% CI: 0.14, 0.59; 45–54 years: OR= 0.36, 95% CI: 0.20, 0.66). Specifically, having higher DRF, high anxiety and insomnia symptoms, high risk of PTSD, lower sleep duration and younger age predict higher NF. The results are reported in <xref rid="t0003" ref-type="table">Table 3</xref>.<table-wrap position="float" id="t0003"><label>Table 3</label><caption><p>Ordinal Logistic Regression Model on Nightmare Frequency in COVID-19 Participants (N=499)</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Covariates</th><th rowspan="2" colspan="1"><italic toggle="yes">OR</italic></th><th rowspan="2" colspan="1"><italic toggle="yes">p</italic></th><th colspan="2" align="center" rowspan="1">95% CI</th></tr><tr><th align="center" rowspan="1" colspan="1">Lower Bound</th><th align="center" rowspan="1" colspan="1">Upper Bound</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Wellbeing (WHO-5)</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.459</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">1.01</td></tr><tr><td rowspan="1" colspan="1">Quality of life</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.835</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">1.01</td></tr><tr><td rowspan="1" colspan="1">Quality of health</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">0.466</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">1.01</td></tr><tr><td rowspan="1" colspan="1">Anxiety</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1.76</td><td rowspan="1" colspan="1"><bold>0.018</bold></td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1">2.81</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1.41</td><td rowspan="1" colspan="1">0.157</td><td rowspan="1" colspan="1">0.88</td><td rowspan="1" colspan="1">2.28</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Stress</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">0.82</td><td rowspan="1" colspan="1">0.388</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">1.28</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">PTSD (repeated disturbing thoughts/memories)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">High risk</td><td rowspan="1" colspan="1">2.58</td><td rowspan="1" colspan="1"><bold>&lt;0.001</bold></td><td rowspan="1" colspan="1">1.67</td><td rowspan="1" colspan="1">3.96</td></tr><tr><td rowspan="1" colspan="1">Low risk</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">DRF</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Nightly or almost nightly</td><td rowspan="1" colspan="1">19.26</td><td rowspan="1" colspan="1"><bold>&lt;0.001</bold></td><td rowspan="1" colspan="1">9.38</td><td rowspan="1" colspan="1">39.57</td></tr><tr><td rowspan="1" colspan="1">3–5 nights per week</td><td rowspan="1" colspan="1">11.54</td><td rowspan="1" colspan="1"><bold>&lt;0.001</bold></td><td rowspan="1" colspan="1">6.01</td><td rowspan="1" colspan="1">22.14</td></tr><tr><td rowspan="1" colspan="1">1–2 nights per week</td><td rowspan="1" colspan="1">9.67</td><td rowspan="1" colspan="1"><bold>&lt;0.001</bold></td><td rowspan="1" colspan="1">5.11</td><td rowspan="1" colspan="1">18.31</td></tr><tr><td rowspan="1" colspan="1">Less than weekly</td><td rowspan="1" colspan="1">2.82</td><td rowspan="1" colspan="1"><bold>0.002</bold></td><td rowspan="1" colspan="1">1.47</td><td rowspan="1" colspan="1">5.41</td></tr><tr><td rowspan="1" colspan="1">Never or less than monthly</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Insomnia</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1.63</td><td rowspan="1" colspan="1"><bold>0.039</bold></td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">2.60</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sleep quality</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Poor</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.935</td><td rowspan="1" colspan="1">0.65</td><td rowspan="1" colspan="1">1.48</td></tr><tr><td rowspan="1" colspan="1">Good</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sleep duration</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Long</td><td rowspan="1" colspan="1">0.43</td><td rowspan="1" colspan="1"><bold>0.003</bold></td><td rowspan="1" colspan="1">0.25</td><td rowspan="1" colspan="1">0.75</td></tr><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.55</td><td rowspan="1" colspan="1"><bold>0.010</bold></td><td rowspan="1" colspan="1">0.35</td><td rowspan="1" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">Short</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COVID-19 severity</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">High</td><td rowspan="1" colspan="1">1.60</td><td rowspan="1" colspan="1"><bold>0.014</bold></td><td rowspan="1" colspan="1">1.10</td><td rowspan="1" colspan="1">2.34</td></tr><tr><td rowspan="1" colspan="1">Low</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Quarantine duration</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&gt; 1 month</td><td rowspan="1" colspan="1">0.95</td><td rowspan="1" colspan="1">0.781</td><td rowspan="1" colspan="1">0.66</td><td rowspan="1" colspan="1">1.37</td></tr><tr><td rowspan="1" colspan="1">≤ 1 month</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">0.121</td><td rowspan="1" colspan="1">0.52</td><td rowspan="1" colspan="1">1.08</td></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">65+</td><td rowspan="1" colspan="1">0.49</td><td rowspan="1" colspan="1">0.078</td><td rowspan="1" colspan="1">0.22</td><td rowspan="1" colspan="1">1.08</td></tr><tr><td rowspan="1" colspan="1">55–64</td><td rowspan="1" colspan="1">0.29</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">0.14</td><td rowspan="1" colspan="1">0.59</td></tr><tr><td rowspan="1" colspan="1">45–54</td><td rowspan="1" colspan="1">0.36</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">35–44</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">0.378</td><td rowspan="1" colspan="1">0.46</td><td rowspan="1" colspan="1">1.34</td></tr><tr><td rowspan="1" colspan="1">25–34</td><td rowspan="1" colspan="1">0.71</td><td rowspan="1" colspan="1">0.247</td><td rowspan="1" colspan="1">0.39</td><td rowspan="1" colspan="1">1.27</td></tr><tr><td rowspan="1" colspan="1">&lt;25</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0004"><p><bold>Note</bold>: Significant values are indicated in bold.</p></fn><fn id="tfn0005"><p><bold>Abbreviations</bold>: OR, odd ratio; CI, confidence interval; PTSD, post-traumatic stress disorder; Ref, reference.</p></fn></table-wrap-foot></table-wrap>
</p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p>To date, this is the first study investigating oneiric activity in subjects who have had COVID-19 in comparison to controls. First, consistent with previous findings, we observed that both participants with and without COVID-19 had higher dream activity during the pandemic than pre-pandemic.<xref rid="cit0021" ref-type="bibr">21–24</xref></p>
      <p>Importantly, during the pandemic, NF was significantly higher in the COVID-19 participants than the controls, as hypothesized. This increased nightmare rate may be a consequence of traumatic experience.<xref rid="cit0052" ref-type="bibr">52</xref>,<xref rid="cit0053" ref-type="bibr">53</xref> Coherently, we found that having repeated disturbing thoughts/memories as a PTSD symptom, as well as anxiety, were associated with greater NF.</p>
      <p>It should be considered that our data were collected during the “first wave” of the COVID-19 pandemic when knowledge about the virus was very poor.<xref rid="cit0054" ref-type="bibr">54</xref> The scarce or inadequate information on the disease and its treatment, as well as the social stigmatization after diagnosis, was related to fear and feeling of uncertainty, and these factors could induce PTSD-like symptoms.<xref rid="cit0055" ref-type="bibr">55</xref></p>
      <p>Interestingly, we revealed that high COVID-19 disease severity predicted greater NF. Hence, people who had developed a moderate/severe or life-threatening disease reported more nightmares. Although we did not have any information about the contents or “recurring nightmares”, the high NF could be a symptom of PTSD, following what was likely qualified as a traumatic event.<xref rid="cit0056" ref-type="bibr">56</xref> We could speculate that the lack of contact with families or friends during forced quarantine and/or hospitalization may have induced higher PTSD symptoms and -as a consequence- higher NF.<xref rid="cit0057" ref-type="bibr">57</xref> Separate from experiencing a potentially traumatic experience, the presence of several nightmares after the illness may also be an attempt to cope with the COVID-19-related negative emotions. Nightmares were proposed to reflect a failure in emotional regulation processes after events characterized by significant distress.<xref rid="cit0058" ref-type="bibr">58</xref> Also, nightmares are associated with other symptoms of psychopathology and suicidal behavior independent of PTSD symptoms,<xref rid="cit0039" ref-type="bibr">39</xref>,<xref rid="cit0040" ref-type="bibr">40</xref> suggesting that nightmares may be also having a notable impact on the participant’s life.</p>
      <p>Additionally, we found that clinical insomnia was strictly related to higher NF in COVID-19 cases. In parallel, higher sleep duration (normal or long) was associated with lower NF. Our results are consistent with the observations during the pandemic without assessing the influence of COVID-19 infection (eg,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0024" ref-type="bibr">24</xref>) and with the current literature on dreaming.<xref rid="cit0059" ref-type="bibr">59</xref> Poor sleep, as in the case of insomnia, promotes higher oneiric frequency.<xref rid="cit0059" ref-type="bibr">59</xref> This evidence is supported by electroencephalographic (EEG) studies reporting that fragmented sleep, higher intra-sleep wakefulness, and greater cortical activation are related to high DRF<xref rid="cit0060" ref-type="bibr">60–62</xref> and - more directly - to NF.<xref rid="cit0063" ref-type="bibr">63–65</xref> The association between insomnia and NF may also be the expression of underlying psychiatric problems, as insomnia and nightmares are both symptoms of depression and PTSD.<xref rid="cit0066" ref-type="bibr">66</xref> Also, a previous study found that risks of insomnia were higher among COVID-19 participants.<xref rid="cit0013" ref-type="bibr">13</xref></p>
      <p>Accordingly, given that nightmares have been shown to be associated with many forms of psychopathology,<xref rid="cit0035" ref-type="bibr">35</xref> the presence of nightmares may also be related to the increased psychiatric symptomatology. Indeed, COVID-19 participants had more psychiatric symptoms than controls: they reported not only greater PTSD symptoms but also more anxiety and depression. Conversely, the wellbeing measures were significantly higher in the controls. Similarly, a recent meta-analysis revealed a high prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients.<xref rid="cit0003" ref-type="bibr">3</xref> Moreover, Poyraz et al<xref rid="cit0055" ref-type="bibr">55</xref> found that patients who had recovered from the acute COVID-19 reported not only clinically relevant PTSD but also anxiety, and depressive symptoms.</p>
      <p>Our findings are in line with this research, with the COVID-19 participants not only experiencing increased nightmares but also significantly higher symptoms of mental disorders. Further research is warranted to delve deeper into these complex relations to determine whether either the trauma associated with having COVID-19, or the presence of nightmares may be underlying these differences in mental disorders.</p>
      <p>Similar to the available literature on pandemic dreams,<xref rid="cit0021" ref-type="bibr">21</xref>,<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0024" ref-type="bibr">24</xref> we confirmed that there is an “age-effect” on oneiric activity. Although nightmares and disturbing dreams in older people are scarcely investigated,<xref rid="cit0067" ref-type="bibr">67</xref> the age-related decline of nightmares may be linked to a reduced motivation to recall dream activity during aging.<xref rid="cit0068" ref-type="bibr">68</xref>,<xref rid="cit0069" ref-type="bibr">69</xref></p>
      <p>Moreover, we found that DRF and NF were associated in the COVID-19 group, and these two phenomena were also related in the wider sample examined in the previous study by the ICOSS group.<xref rid="cit0022" ref-type="bibr">22</xref> Accordingly, other studies have also found an association between DRF and NF in the general population.<xref rid="cit0070" ref-type="bibr">70–72</xref> Overall, considering results on the whole sample,<xref rid="cit0022" ref-type="bibr">22</xref> it should be expected that the more people were affected by the COVID-19 pandemic, the more dream activity would also be affected. In other words, individuals’ oneiric activity, in general, and nightmare frequency, more specifically, may represent a reliable index of wellbeing or discomfort. Indeed, our findings are consistent with this hypothesis, showing strong associations between increased nightmares and reduced quality of life in those reporting having had COVID-19.</p>
      <p>A strength of the current study was that data were collected using the same methodology among different countries matching controls and infected subjects by country. However, we believe that further studies should specifically assess differences between nations since the unbalanced distribution of COVID-19 cases and the number deaths varied greatly from region to region (ie, the possibility of traumatic experiences may vary greatly) in our sample did not allow us to address this issue.</p>
    </sec>
    <sec id="s0005">
      <title>Limitations</title>
      <p>The current investigation has some limitations. First, data collected were “double retrospective” because we required participants to give information “before” and “during” pandemic, which has an intrinsic problem of “memory bias”.<xref rid="cit0073" ref-type="bibr">73</xref> Second, the original version of the Basic Nordic sleep questionnaire<xref rid="cit0048" ref-type="bibr">48</xref> does not include questions regarding DRF and NF; indeed, the two questions were specially added to the questionnaire. This could be considered a limitation of our protocol since the test with these two “new” items was not standardized. Third, the information about the COVID-19 severity was self-reported and this would imply that the “severity” of the disease was not objectively evaluated by a physician/medical healthcare worker or based on objective measures.</p>
      <p>Further, the survey did not allow collecting information about the physical and mental state of COVID-19 patients before getting the disease. This would represent a limitation since pre-existing health problems, especially mental illness, could have affected the patient’s sleep and dreams.<xref rid="cit0074" ref-type="bibr">74</xref></p>
      <p>Also, we do not have any information about how much time has passed since infection among the COVID-19 subjects. This variable may be essential to better understand the relationship between higher nightmares and the severity of infection. We are aware that in some cases, COVID-19 symptoms may still persist at the time of the survey. In other words, participants may have responded to the questionnaire during or after the infection. Also, the existence of a post-acute COVID-19 syndrome (long-COVID-19)<xref rid="cit0075" ref-type="bibr">75</xref> may impact on dream activity and sleep quality. In this respect, our results should be interpreted with caution since we cannot disentangle whether some effects on oneiric experience were related to the persistence of symptoms or associated with the past experience. Lastly, except for the hypnotics’ usage, information on specific types of medications and ongoing treatments was not available. It should be considered that dreams and nightmares can be affected by medication use.<xref rid="cit0076" ref-type="bibr">76</xref> In particular, the pharmacological therapy for COVID-19 patients may include drugs (eg, anodyne, glucocorticoids) that have been reported to affect users’ sleep and dreams.<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0077" ref-type="bibr">77</xref></p>
      <p>Finally, it is worth noting that this current ICOSS protocol focused on the first wave of the pandemic instead of the COVID-19 infection per se. A second survey was done to answer the important questions related to COVID-19 and comorbidities, also addressing the long-COVID-19 issue.<xref rid="cit0078" ref-type="bibr">78</xref></p>
    </sec>
    <sec id="s0006">
      <title>Conclusion</title>
      <p>In summary, we suggest that dream characteristics and, above all, nightmares are possible correlates of COVID-19. Our study is unable to determine if the effects on dreaming activity are explained by the infection per se or by its impact on the general psychological and mental adaptation to the infection. Nevertheless, our work is an important first step in understanding the effects of COVID-19 on dreams and nightmares. Further investigations on longitudinal assessment of changes in sleep and dreaming during pandemic focusing on participants who have had COVID-19 and those with long-COVID-19 are warranted.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We would like to acknowledge all ICOSS group collaborators.</p>
    </ack>
    <sec id="s0007">
      <title>Abbreviations</title>
      <p>WHO, World Health Organization; COVID-19, Coronavirus disease 19; DRF, Dream Recall Frequency; Nightmare Frequency, NF; PTSD, Post-Traumatic Stress Disorder; GAD-2, Generalized Anxiety Disorder-2; PHQ-2, Patient Health Questionnaire-2; WHO-5, Well-Being Index; ISI, Insomnia Severity Index; OR, Odds Ratio; CI, Confidence Interval.</p>
    </sec>
    <sec id="s0008">
      <title>Data Sharing Statement</title>
      <p>Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.</p>
    </sec>
    <sec id="s0009">
      <title>Ethics Approval</title>
      <p>All investigators obtained ethical approval or exemptions from their local ethics committee. The study was approved by the Institutional Ethics Committee of the Department of Psychology of “Sapienza” University of Rome and was conducted in accordance with the Declaration of Helsinki (protocol number: 0000836, May 23rd, 2020). Participants voluntarily and anonymously agreed to take part in the survey. General data protection regulations were applied to ensure privacy and confidentiality.</p>
    </sec>
    <sec id="s0010">
      <title>Author Contributions</title>
      <p>All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</p>
    </sec>
    <sec sec-type="COI-statement" id="s0011">
      <title>Disclosure</title>
      <p>Dr Frances Chung reports personal fees as a consultant from Takeda Pharma, outside the submitted work. Professor Colin A Espie is a Co-Founder and Chief Scientist of, and a shareholder in, Big Health the company that that developed Sleepio a digital CBT intervention for insomnia. Professor Yuichi Inoue reports personal fees in speaking activity from Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and MSD K.K.; in addition, Professor Yuichi Inoue also reports the Department of Somnology is an endowment department, supported by an unrestricted grant from Phillips Japan, Ltd and KOIKE MEDICAL Co., LTD, outside the submitted work. Dr Kentaro Matsui reports personal fees from Eisai, Meiji Seika Pharma, MSD, Otsuka, Yoshitomi, and Takeda, outside the submitted work. Professor Charles M Morin reports grants from Idorsia, Eisai, l’allemand Health, outside the submitted work; and royalties from Mapi Research Trust. Professor Thomas Penzel reports grants or personal fees for speaker fee and consultation from Cidelec, Phasya, Neuwirth, Jazz, Cerebra, and National Sleep Foundation. He also owns shares from The Siesta Group, outside the submitted work. The authors report no other conflicts of interest in this work.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Blanco</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wall</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Olfson</surname>
<given-names>M</given-names></string-name>. <article-title>Psychological aspects of the COVID-19 pandemic</article-title>. <source><italic toggle="yes">J Gen Intern Med</italic></source>. <year>2020</year>;<volume>35</volume>:<fpage>2757</fpage>–<lpage>2759</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11606-020-05955-3</pub-id><pub-id pub-id-type="pmid">32542499</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vindegaard</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Benros</surname>
<given-names>ME</given-names></string-name>. <article-title>COVID-19 pandemic and mental health consequences: systematic review of the current evidence</article-title>. <source><italic toggle="yes">Brain Behav Immun</italic></source>. <year>2020</year>;<volume>89</volume>:<fpage>531</fpage>–<lpage>542</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbi.2020.05.048</pub-id><pub-id pub-id-type="pmid">32485289</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Deng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>W</given-names></string-name>, et al. <article-title>The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis</article-title>. <source><italic toggle="yes">Ann N Y Acad Sci</italic></source>. <year>2021</year>;<volume>1486</volume>:<fpage>90</fpage>–<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1111/nyas.14506</pub-id><pub-id pub-id-type="pmid">33009668</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Altena</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Baglioni</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Espie</surname>
<given-names>CA</given-names></string-name>, et al. <article-title>Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2020</year>;<volume>29</volume>(<issue>4</issue>):<fpage>e13052</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13052</pub-id><pub-id pub-id-type="pmid">32246787</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Blume</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Schmidt</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Cajochen</surname>
<given-names>C</given-names></string-name>. <article-title>Effects of the COVID-19 lockdown on human sleep and rest-activity rhythms</article-title>. <source><italic toggle="yes">Curr Biol</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>795</fpage>–<lpage>797</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2020.06.021</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>CasaGrande</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Favieri</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tambelli</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Forte</surname>
<given-names>G</given-names></string-name>. <article-title>The enemy who sealed the world: effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2020</year>;<volume>75</volume>:<fpage>12</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2020.05.011</pub-id><pub-id pub-id-type="pmid">32853913</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cellini</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Canale</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Mioni</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Costa</surname>
<given-names>S</given-names></string-name>. <article-title>Changes in sleep pattern, sense of time and digital media use during COVID‐19 lockdown in Italy</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2020</year>;<volume>29</volume>:<fpage>e13074</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13074</pub-id><pub-id pub-id-type="pmid">32410272</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alfonsi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gorgoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, et al. <article-title>COVID-19 lockdown and poor sleep quality: not the whole story</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2021</year>;<volume>30</volume>:<fpage>e13368</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13368</pub-id><pub-id pub-id-type="pmid">33955081</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Franceschini</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Musetti</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zenesini</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Poor quality of sleep and its consequences on mental health during COVID-19 lockdown in Italy</article-title>. <source><italic toggle="yes">Front Psychol</italic></source>. <year>2020</year>;<volume>11</volume>:<fpage>3072</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2020.574475</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wright</surname>
<given-names>KP</given-names></string-name>, <string-name><surname>Linton</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Withrow</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Sleep in University students prior to and during COVID-19 stay-at-home orders</article-title>. <source><italic toggle="yes">Curr Biol</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>797</fpage>–<lpage>798</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2020.06.022</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Q</given-names></string-name>, et al. <article-title>Insomnia and psychological reactions during the COVID-19 outbreak in China</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>:<fpage>1417</fpage>–<lpage>1418</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8524</pub-id><pub-id pub-id-type="pmid">32351206</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jahrami</surname>
<given-names>H</given-names></string-name>, <string-name><surname>BaHammam</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Bragazzi</surname>
<given-names>NL</given-names></string-name>, et al. <article-title>Sleep problems during the COVID-19 pandemic by population: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2021</year>;<volume>17</volume>:<fpage>299</fpage>–<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8930</pub-id><pub-id pub-id-type="pmid">33108269</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Bjorvatn</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Insomnia, anxiety, and depression during the COVID-19 pandemic: an International Collaborative Study</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2021</year>;<volume>87</volume>:<fpage>38</fpage>–<lpage>45</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2021.07.035</pub-id><pub-id pub-id-type="pmid">34508986</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ferrando</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bagnasco</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Roustan</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Canonica</surname>
<given-names>GW</given-names></string-name>, <string-name><surname>Braido</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Baiardini</surname>
<given-names>I</given-names></string-name>. <article-title>Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases</article-title>. <source><italic toggle="yes">J Thorac Dis</italic></source>. <year>2016</year>;<volume>8</volume>(<issue>8</issue>):<fpage>E716</fpage>–<lpage>E725</lpage>. doi:<pub-id pub-id-type="doi">10.21037/jtd.2016.07.82</pub-id><pub-id pub-id-type="pmid">27621908</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="book"><string-name><surname>Singh</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Jamil</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Mahajan</surname>
<given-names>K</given-names></string-name>. <part-title>Nocturnal cough</part-title>. In: <string-name><surname>Cascella</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rajnik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cuomo</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dulebohn</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Di Napoli</surname>
<given-names>RS</given-names></string-name>, editors. <source><italic toggle="yes">StatPearls</italic></source>. <publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>Stat Pearls Publishing</publisher-name>; <year>2020</year>.</mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Que</surname>
<given-names>JY</given-names></string-name>, et al. <article-title>Prevalence of and risk factors associated with mental health symptoms among the general population in China during the coronavirus disease 2019 pandemic</article-title>. <source><italic toggle="yes">JAMA Netw Open</italic></source>. <year>2020</year>;<volume>3</volume>:<fpage>e2014053</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.14053</pub-id><pub-id pub-id-type="pmid">32609353</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wesselius</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Van Den Ende</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Alsma</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Quality and quantity of sleep and factors associated with sleep disturbance in hospitalized patients</article-title>. <source><italic toggle="yes">JAMA Int Med</italic></source>. <year>2018</year>;<volume>178</volume>:<fpage>1201</fpage>–<lpage>1208</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamainternmed.2018.2669</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Barrett</surname>
<given-names>D</given-names></string-name>. <article-title>Dreams about COVID-19 versus normative dreams: trends by gender</article-title>. <source><italic toggle="yes">Dreaming</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>216</fpage>–<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1037/drm0000149</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Pesonen</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Lipsanen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Halonen</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Pandemic dreams: network analysis of dream content during the COVID-19 lockdown</article-title>. <source><italic toggle="yes">Front Psychol</italic></source>. <year>2020</year>;<volume>11</volume>:<fpage>2569</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2020.573961</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Iorio</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Sommantico</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Parrello</surname>
<given-names>S</given-names></string-name>. <article-title>Dreaming in the time of COVID-19: a quali-quantitative Italian study</article-title>. <source><italic toggle="yes">Dreaming</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>199</fpage>. doi:<pub-id pub-id-type="doi">10.1037/drm0000142</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Gorgoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alfonsi</surname>
<given-names>V</given-names></string-name>, et al. <article-title>Pandemic dreams: quantitative and qualitative features of the oneiric activity during the lockdown due to COVID-19 in Italy</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2021</year>;<volume>81</volume>:<fpage>20</fpage>–<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2021.02.006</pub-id><pub-id pub-id-type="pmid">33631710</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Fränkl</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Nadorff</surname>
<given-names>MR</given-names></string-name>, et al. <article-title>How our dreams changed during the COVID-19 pandemic: effects and correlates of dream recall frequency during the COVID-19 pandemic: a Multinational Study on 19,355 adults</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2021</year>;<volume>13</volume>:<fpage>1573</fpage>–<lpage>1591</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S324142</pub-id><pub-id pub-id-type="pmid">34588830</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mota</surname>
<given-names>NB</given-names></string-name>, <string-name><surname>Weissheimer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Dreaming during the COVID-19 pandemic: computational assessment of dream reports reveals mental suffering related to fear of contagion</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2020</year>;<volume>15</volume>:<fpage>e0242903</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0242903</pub-id><pub-id pub-id-type="pmid">33253274</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alfonsi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Mangiaruga</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Pandemic nightmares: effects on dream activity of the COVID-19 lockdown in Italy</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2021</year>;<volume>30</volume>:<fpage>e13300</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13300</pub-id><pub-id pub-id-type="pmid">33547703</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gorgoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alfonsi</surname>
<given-names>V</given-names></string-name>, et al. <article-title>The impact of the end of COVID confinement on pandemic dreams, as assessed by a weekly sleep diary: a longitudinal investigation in Italy</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2021</year>:<fpage>e13429</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13429</pub-id><pub-id pub-id-type="pmid">34288197</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schredl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Reinhard</surname>
<given-names>I</given-names></string-name>. <article-title>Gender differences in nightmare frequency: a meta-analysis</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2011</year>;<volume>15</volume>:<fpage>115</fpage>–<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2010.06.002</pub-id><pub-id pub-id-type="pmid">20817509</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schredl</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bulkeley</surname>
<given-names>K</given-names></string-name>. <article-title>Dreaming and the COVID-19 pandemic: a survey in a US sample</article-title>. <source><italic toggle="yes">Dreaming</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>189</fpage>. doi:<pub-id pub-id-type="doi">10.1037/drm0000146</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>MacKay</surname>
<given-names>C</given-names></string-name>, <string-name><surname>DeCicco</surname>
<given-names>TL</given-names></string-name>. <article-title>Pandemic dreaming: the effect of COVID-19 on dream imagery, a pilot study</article-title>. <source><italic toggle="yes">Dreaming</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>222</fpage>. doi:<pub-id pub-id-type="doi">10.1037/drm0000148</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>The psychological distress and coping styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic in the general mainland Chinese population: a web-based survey</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2020</year>;<volume>15</volume>:<fpage>e0233410</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0233410</pub-id><pub-id pub-id-type="pmid">32407409</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Becker</surname>
<given-names>RC</given-names></string-name>. <article-title>Anticipating the long-term cardiovascular effects of COVID-19</article-title>. <source><italic toggle="yes">J Thromb Thrombolysis</italic></source>. <year>2020</year>;<volume>50</volume>:<fpage>512</fpage>–<lpage>524</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11239-020-02266-6</pub-id><pub-id pub-id-type="pmid">32880795</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Del Rio</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Malani</surname>
<given-names>P</given-names></string-name>. <article-title>Long-term health consequences of COVID-19</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2020</year>;<volume>324</volume>:<fpage>1723</fpage>–<lpage>1724</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2020.19719</pub-id><pub-id pub-id-type="pmid">33031513</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heneka</surname>
<given-names>MT</given-names></string-name>, <string-name><surname>Golenbock</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Latz</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Morgan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>R</given-names></string-name>. <article-title>Immediate and long-term consequences of COVID-19 infections for the development of neurological disease</article-title>. <source><italic toggle="yes">Alzheimers Res Ther</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>1</fpage>–<lpage>3</lpage>. doi:<pub-id pub-id-type="doi">10.1186/s13195-020-00640-3</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ritchie</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Watermeyer</surname>
<given-names>T</given-names></string-name>. <article-title>The cognitive consequences of the COVID-19 epidemic: collateral damage?</article-title>
<source><italic toggle="yes">Brain Commun</italic></source>. <year>2020</year>;<volume>2</volume>:<fpage>fcaa069</fpage>. doi:<pub-id pub-id-type="doi">10.1093/braincomms/fcaa069</pub-id><pub-id pub-id-type="pmid">33074266</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Iqbal</surname>
<given-names>SZ</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Onigu-Otito</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Faraz Naqui</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shah</surname>
<given-names>AA</given-names></string-name>. <article-title>The long-term mental health effects of COVID-19</article-title>. <source><italic toggle="yes">Psychiatr Ann</italic></source>. <year>2020</year>;<volume>50</volume>:<fpage>522</fpage>–<lpage>525</lpage>. doi:<pub-id pub-id-type="doi">10.3928/00485713-20201103-01</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nadorff</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Nazem</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fiske</surname>
<given-names>A</given-names></string-name>. <article-title>Insomnia symptoms, nightmares, and suicidal ideation in a college student sample</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2011</year>;<volume>34</volume>:<fpage>93</fpage>–<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/34.1.93</pub-id><pub-id pub-id-type="pmid">21203379</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Selby</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Ribeiro</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Joiner</surname>
<given-names>TE</given-names>
<suffix>Jr</suffix></string-name>. <article-title>What dreams may come: emotional cascades and nightmares in borderline personality disorder</article-title>. <source><italic toggle="yes">Dreaming</italic></source>. <year>2013</year>;<volume>23</volume>:<fpage>126</fpage>–<lpage>144</lpage>. doi:<pub-id pub-id-type="doi">10.1037/a0032208</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tanskanen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tuomilehto</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Viinamäki</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Vartiainen</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Lehtonen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Puska</surname>
<given-names>P</given-names></string-name>. <article-title>Nightmares as predictors of suicide</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2001</year>;<volume>24</volume>:<fpage>845</fpage>–<lpage>848</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/24.7.845</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>SX</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Mandy</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wing</surname>
<given-names>YK</given-names></string-name>. <article-title>Nocturnal sleep disturbances as a predictor of suicide attempts among psychiatric outpatients: a clinical, epidemiologic, prospective study</article-title>. <source><italic toggle="yes">J Clin Psychiatry</italic></source>. <year>2010</year>;<volume>71</volume>:<fpage>1440</fpage>–<lpage>1446</lpage>. doi:<pub-id pub-id-type="doi">10.4088/JCP.09m05661gry</pub-id><pub-id pub-id-type="pmid">21114949</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Sjöström</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Hetta</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Waern</surname>
<given-names>M</given-names></string-name>. <article-title>Persistent nightmares are associated with repeat suicide attempt: a prospective study</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>2009</year>;<volume>170</volume>:<fpage>208</fpage>–<lpage>211</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2008.09.006</pub-id><pub-id pub-id-type="pmid">19900715</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nadorff</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Nazem</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Fiske</surname>
<given-names>A</given-names></string-name>. <article-title>Insomnia symptoms, nightmares, and suicide risk: duration of sleep disturbance matters</article-title>. <source><italic toggle="yes">Suicide Life Threat Behav</italic></source>. <year>2013</year>;<volume>43</volume>:<fpage>139</fpage>–<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1111/sltb.12003</pub-id><pub-id pub-id-type="pmid">23278677</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Partinen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bjorvatn</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Holzinger</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Penzel</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Espie</surname>
<given-names>CA</given-names></string-name>; <collab>ICOSS-collaboration group</collab>. <article-title>Sleep and circadian problems during the coronavirus disease 2019 (COVID‐19) pandemic: the International COVID‐19 Sleep Study (ICOSS)</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2021</year>;<volume>30</volume>:<fpage>e13206</fpage>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13206</pub-id><pub-id pub-id-type="pmid">33179820</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Yegneswaran</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Liao</surname>
<given-names>P</given-names></string-name>, et al. <article-title>STOP questionnaire: a tool to screen patients for obstructive sleep apnea</article-title>. <source><italic toggle="yes">Anesthesiology</italic></source>. <year>2008</year>;<volume>108</volume>:<fpage>812</fpage>–<lpage>821</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ALN.0b013e31816d83e4</pub-id><pub-id pub-id-type="pmid">18431116</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kroenke</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Spitzer</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>JBW</given-names></string-name>, <string-name><surname>Löwe</surname>
<given-names>B</given-names></string-name>. <article-title>An ultra-brief screening scale for anxiety and depression: the PHQ-4</article-title>. <source><italic toggle="yes">Psychosomatics</italic></source>. <year>2009</year>;<volume>50</volume>:<fpage>613</fpage>–<lpage>621</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.psy.50.6.613</pub-id><pub-id pub-id-type="pmid">19996233</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Elo</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Leppänen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jahkola</surname>
<given-names>A</given-names></string-name>. <article-title>Validity of a single-item measure of stress symptoms</article-title>. <source><italic toggle="yes">Scand J Work Environ Health</italic></source>. <year>2003</year>;<volume>29</volume>:<fpage>444</fpage>–<lpage>451</lpage>. doi:<pub-id pub-id-type="doi">10.5271/sjweh.752</pub-id><pub-id pub-id-type="pmid">14712852</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lang</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Wilkins</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Roy-Byrne</surname>
<given-names>PP</given-names></string-name>, et al. <article-title>Abbreviated PTSD checklist (PCL) as a guide to clinical response</article-title>. <source><italic toggle="yes">Gen Hosp Psychiatry</italic></source>. <year>2012</year>;<volume>34</volume>:<fpage>332</fpage>–<lpage>338</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2012.02.003</pub-id><pub-id pub-id-type="pmid">22460001</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Topp</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Østergaard</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Søndergaard</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bech</surname>
<given-names>P</given-names></string-name>. <article-title>The WHO-5 wellbeing index: a systematic review of the literature</article-title>. <source><italic toggle="yes">Psychother Psychosom</italic></source>. <year>2015</year>;<volume>84</volume>:<fpage>167</fpage>–<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000376585</pub-id><pub-id pub-id-type="pmid">25831962</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Boer</surname>
<given-names>AGEM</given-names></string-name>, <string-name><surname>van Lanschot</surname>
<given-names>JJB</given-names></string-name>, <string-name><surname>Stalmeier</surname>
<given-names>PFM</given-names></string-name>, et al. <article-title>Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?</article-title>
<source><italic toggle="yes">Qual Life Res</italic></source>. <year>2004</year>;<volume>13</volume>:<fpage>311</fpage>–<lpage>320</lpage>. doi:<pub-id pub-id-type="doi">10.1023/B:QURE.0000018499.64574.1f</pub-id><pub-id pub-id-type="pmid">15085903</pub-id></mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Partinen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gislason</surname>
<given-names>T</given-names></string-name>. <article-title>Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>1995</year>;<volume>4</volume>:<fpage>150</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2869.1995.tb00205.x</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Morin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Belleville</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bélanger</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ivers</surname>
<given-names>H</given-names></string-name>. <article-title>The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2011</year>;<volume>34</volume>:<fpage>601</fpage>–<lpage>608</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/34.5.601</pub-id><pub-id pub-id-type="pmid">21532953</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aeschbach</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Postolache</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Giesen</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Wehr</surname>
<given-names>TA</given-names></string-name>. <article-title>Two circadian rhythms in the human electroencephalogram during wakefulness</article-title>. <source><italic toggle="yes">Am J Physiol Reg I</italic></source>. <year>1999</year>;<volume>277</volume>:<fpage>R1771</fpage>–<lpage>R1779</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpregu.1999.277.6.R1771</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aeschbach</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Sher</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Postolache</surname>
<given-names>TT</given-names></string-name>, <string-name><surname>Matthews</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Wehr</surname>
<given-names>TA</given-names></string-name>. <article-title>A longer biological night in long sleepers than in short sleepers</article-title>. <source><italic toggle="yes">J Clin Endocrinol Metab</italic></source>. <year>2003</year>;<volume>88</volume>:<fpage>26</fpage>–<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.1210/jc.2002-020827</pub-id><pub-id pub-id-type="pmid">12519823</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Neylan</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Marmar</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Metzler</surname>
<given-names>TJ</given-names></string-name>, et al. <article-title>Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans</article-title>. <source><italic toggle="yes">Am J Psychiatry</italic></source>. <year>1998</year>;<volume>155</volume>:<fpage>929</fpage>–<lpage>933</lpage>. doi:<pub-id pub-id-type="doi">10.1176/ajp.155.7.929</pub-id><pub-id pub-id-type="pmid">9659859</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tempesta</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Curcio</surname>
<given-names>G</given-names></string-name>, <string-name><surname>De Gennaro</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ferrara</surname>
<given-names>M</given-names></string-name>. <article-title>Long-term impact of earthquakes on sleep quality</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>:<fpage>e55936</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0055936</pub-id><pub-id pub-id-type="pmid">23418478</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mian</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khan</surname>
<given-names>S</given-names></string-name>. <article-title>Coronavirus: the spread of misinformation</article-title>. <source><italic toggle="yes">BMC Med</italic></source>. <year>2020</year>;<volume>18</volume>:<fpage>1</fpage>–<lpage>2</lpage>. doi:<pub-id pub-id-type="doi">10.1186/s12916-020-01556-3</pub-id><pub-id pub-id-type="pmid">31898501</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Poyraz</surname>
<given-names>BÇ</given-names></string-name>, <string-name><surname>Poyraz</surname>
<given-names>CA</given-names></string-name>, <string-name><surname>Olgun</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Psychiatric morbidity and protracted symptoms after COVID-19</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>2021</year>;<volume>295</volume>:<fpage>113604</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psychres.2020.113604</pub-id><pub-id pub-id-type="pmid">33296818</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="book"><collab>American Psychiatric Association</collab>. <source><italic toggle="yes">Diagnostic and Statistical Manual of Mental Disorders: DSM-5</italic></source>. <edition>4th</edition> ed. <publisher-loc>Arlington, VA</publisher-loc>: <publisher-name>American Psychiatric Publishing</publisher-name>; <year>2013</year>.</mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dubey</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Biswas</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ghosh</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Psychosocial impact of COVID-19</article-title>. <source><italic toggle="yes">Diabetes Metab Syndr</italic></source>. <year>2020</year>;<volume>14</volume>:<fpage>779</fpage>–<lpage>788</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.dsx.2020.05.035</pub-id><pub-id pub-id-type="pmid">32526627</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Levin</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>T</given-names></string-name>. <article-title>Nightmares, bad dreams, and emotion dysregulation: a review and new neurocognitive model of dreaming</article-title>. <source><italic toggle="yes">Curr Dir Psychol Sci</italic></source>. <year>2009</year>;<volume>18</volume>:<fpage>84</fpage>–<lpage>88</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1467-8721.2009.01614.x</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schredl</surname>
<given-names>M</given-names></string-name>. <article-title>Dreams in patients with sleep disorders</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2009</year>;<volume>13</volume>:<fpage>215</fpage>–<lpage>221</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2008.06.002</pub-id><pub-id pub-id-type="pmid">19147378</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>D’Atri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Schiappa</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Cortical activation during sleep predicts dream experience in narcolepsy</article-title>. <source><italic toggle="yes">Ann Clin Transl Neur</italic></source>. <year>2019</year>;<volume>6</volume>:<fpage>445</fpage>–<lpage>455</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.718</pub-id></mixed-citation>
      </ref>
      <ref id="cit0061">
        <label>61.</label>
        <mixed-citation publication-type="journal"><string-name><surname>van Wyk</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Solms</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Lipinska</surname>
<given-names>G</given-names></string-name>. <article-title>Increased awakenings from non-rapid eye movement sleep explains differences in dream recall frequency in healthy high and low recallers</article-title>. <source><italic toggle="yes">Front Hum Neurosci</italic></source>. <year>2019</year>;<volume>13</volume>:<fpage>370</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fnhum.2019.00370</pub-id><pub-id pub-id-type="pmid">31680920</pub-id></mixed-citation>
      </ref>
      <ref id="cit0062">
        <label>62.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bartolacci</surname>
<given-names>C</given-names></string-name>, <string-name><surname>D’Atri</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Electrophysiological correlates of dream recall during REM sleep: evidence from multiple awakenings and within-subjects design</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>1043</fpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S279786</pub-id><pub-id pub-id-type="pmid">33239931</pub-id></mixed-citation>
      </ref>
      <ref id="cit0063">
        <label>63.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Newell</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Padamadan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Drake</surname>
<given-names>ME</given-names>
<suffix>Jr</suffix></string-name>. <article-title>Neurophysiologic studies in nightmare sufferers</article-title>. <source><italic toggle="yes">Clin Electroencephal</italic></source>. <year>1992</year>;<volume>23</volume>:<fpage>203</fpage>–<lpage>206</lpage>. doi:<pub-id pub-id-type="doi">10.1177/155005949202300410</pub-id></mixed-citation>
      </ref>
      <ref id="cit0064">
        <label>64.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Simor</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bódizs</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Horváth</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ferri</surname>
<given-names>R</given-names></string-name>. <article-title>Disturbed dreaming and the instability of sleep: altered nonrapid eye movement sleep microstructure in individuals with frequent nightmares as revealed by the cyclic alternating pattern</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2013</year>;<volume>36</volume>:<fpage>413</fpage>–<lpage>419</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.2462</pub-id><pub-id pub-id-type="pmid">23449753</pub-id></mixed-citation>
      </ref>
      <ref id="cit0065">
        <label>65.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Van Someren</surname>
<given-names>EJ</given-names></string-name>. <article-title>Brain mechanisms of insomnia: new perspectives on causes and consequences</article-title>. <source><italic toggle="yes">Physiol Rev</italic></source>. <year>2021</year>;<volume>101</volume>:<fpage>995</fpage>–<lpage>1046</lpage>. doi:<pub-id pub-id-type="doi">10.1152/physrev.00046.2019</pub-id><pub-id pub-id-type="pmid">32790576</pub-id></mixed-citation>
      </ref>
      <ref id="cit0066">
        <label>66.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Nakajima</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Inoue</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sasai</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Impact of frequency of nightmares comorbid with insomnia on depression in Japanese rural community residents: a cross-sectional study</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2014</year>;<volume>15</volume>:<fpage>371</fpage>–<lpage>374</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2013.11.785</pub-id><pub-id pub-id-type="pmid">24560189</pub-id></mixed-citation>
      </ref>
      <ref id="cit0067">
        <label>67.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bartolacci</surname>
<given-names>C</given-names></string-name>, <string-name><surname>D’Atri</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gorgoni</surname>
<given-names>M</given-names></string-name>, <string-name><surname>De Gennaro</surname>
<given-names>L</given-names></string-name>. <article-title>Mental sleep activity and disturbing dreams in the lifespan</article-title>. <source><italic toggle="yes">Int J Environ Res Public Health</italic></source>. <year>2019</year>;<volume>16</volume>:<fpage>3658</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph16193658</pub-id></mixed-citation>
      </ref>
      <ref id="cit0068">
        <label>68.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mangiaruga</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Scarpelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bartolacci</surname>
<given-names>C</given-names></string-name>, <string-name><surname>De Gennaro</surname>
<given-names>L</given-names></string-name>. <article-title>Spotlight on dream recall: the ages of dreams</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2018</year>;<volume>10</volume>:<fpage>1</fpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S135762</pub-id><pub-id pub-id-type="pmid">29391838</pub-id></mixed-citation>
      </ref>
      <ref id="cit0069">
        <label>69.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Strunz</surname>
<given-names>F</given-names></string-name>. <article-title>Dreams in the elderly: contents and clinical usefulness</article-title>. <source><italic toggle="yes">Gesundheitswesen</italic></source>. <year>1993</year>;<volume>55</volume>:<fpage>595</fpage>–<lpage>601</lpage>.<pub-id pub-id-type="pmid">8286901</pub-id></mixed-citation>
      </ref>
      <ref id="cit0070">
        <label>70.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Belicki</surname>
<given-names>K</given-names></string-name>. <article-title>Nightmare frequency versus nightmare distress: relation to psychopathology and cognitive style</article-title>. <source><italic toggle="yes">J Abnorm Psychol</italic></source>. <year>1992</year>;<volume>101</volume>:<fpage>592</fpage>–<lpage>597</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0021-843X.101.3.592</pub-id><pub-id pub-id-type="pmid">1500619</pub-id></mixed-citation>
      </ref>
      <ref id="cit0071">
        <label>71.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chivers</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Blagrove</surname>
<given-names>M</given-names></string-name>. <article-title>Nightmare frequency, personality and acute psychopathology</article-title>. <source><italic toggle="yes">Pers Individ Diff</italic></source>. <year>1999</year>;<volume>27</volume>:<fpage>843</fpage>–<lpage>851</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0191-8869(99)00033-1</pub-id></mixed-citation>
      </ref>
      <ref id="cit0072">
        <label>72.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Schredl</surname>
<given-names>M</given-names></string-name>. <article-title>Effects of state and trait factors on nightmare frequency</article-title>. <source><italic toggle="yes">Eur Arch Psychiatry Clin Neurosci</italic></source>. <year>2003</year>;<volume>253</volume>:<fpage>241</fpage>–<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00406-003-0438-1</pub-id><pub-id pub-id-type="pmid">14504993</pub-id></mixed-citation>
      </ref>
      <ref id="cit0073">
        <label>73.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zadra</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Robert</surname>
<given-names>G</given-names></string-name>. <article-title>Dream recall frequency: impact of prospective measures and motivational factors</article-title>. <source><italic toggle="yes">Conscious Cogn</italic></source>. <year>2012</year>;<volume>21</volume>:<fpage>1695</fpage>–<lpage>1702</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.concog.2012.08.011</pub-id><pub-id pub-id-type="pmid">23092675</pub-id></mixed-citation>
      </ref>
      <ref id="cit0074">
        <label>74.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Palagini</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Rosenlicht</surname>
<given-names>N</given-names></string-name>. <article-title>Sleep, dreaming, and mental health: a review of historical and neurobiological perspectives</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2011</year>;<volume>15</volume>:<fpage>179</fpage>–<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2010.07.003</pub-id><pub-id pub-id-type="pmid">20850358</pub-id></mixed-citation>
      </ref>
      <ref id="cit0075">
        <label>75.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Al-Jahdhami</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Al-Naamani</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Al-Mawali</surname>
<given-names>A</given-names></string-name>. <article-title>The post-acute COVID-19 syndrome (long COVID)</article-title>. <source><italic toggle="yes">Oman Med J</italic></source>. <year>2021</year>;<volume>36</volume>:<fpage>e220</fpage>. doi:<pub-id pub-id-type="doi">10.5001/omj.2021.91</pub-id><pub-id pub-id-type="pmid">33537155</pub-id></mixed-citation>
      </ref>
      <ref id="cit0076">
        <label>76.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Siclari</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Valli</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Arnulf</surname>
<given-names>I</given-names></string-name>. <article-title>Dreams and nightmares in healthy adults and in patients with sleep and neurological disorders</article-title>. <source><italic toggle="yes">Lancet Neurol</italic></source>. <year>2020</year>;<volume>19</volume>:<fpage>849</fpage>–<lpage>859</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(20)30275-1</pub-id><pub-id pub-id-type="pmid">32949545</pub-id></mixed-citation>
      </ref>
      <ref id="cit0077">
        <label>77.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Szmyd</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Rogut</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Białasiewicz</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gabryelska</surname>
<given-names>A</given-names></string-name>. <article-title>The impact of glucocorticoids and statins on sleep quality</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2021</year>;<volume>55</volume>:<fpage>101380</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2020.101380</pub-id><pub-id pub-id-type="pmid">33010620</pub-id></mixed-citation>
      </ref>
      <ref id="cit0078">
        <label>78.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Merikanto</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Dauvilliers</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>F</given-names></string-name>, et al.; <collab>ICOSS members</collab>. <article-title>Disturbances in sleep, circadian rhythms, and daytime functioning in relation to coronavirus infection and long-COVID – a multinational ICOSS study</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2021</year>. doi:<pub-id pub-id-type="doi">10.1111/jsr.13542</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
